ClinicalTrials.gov
ClinicalTrials.gov Menu

Clofarabine Salvage Therapy in Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) (BRIDGE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01295307
Recruitment Status : Completed
First Posted : February 14, 2011
Last Update Posted : October 7, 2015
Sponsor:
Collaborator:
Genzyme, a Sanofi Company
Information provided by (Responsible Party):
Schetelig Johannes, Technische Universität Dresden